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ratings on the prospective NIMH life-chart
method (NIMH-LCM)
Christoph Born1*, Benedikt L Amann2,3, Heinz Grunze4, Robert M Post5 and Lars Schärer6Abstract
Background: Careful observation of the longitudinal course of bipolar disorders is pivotal to finding optimal
treatments and improving outcome. A useful tool is the daily prospective Life-Chart Method, developed by the
National Institute of Mental Health. However, it remains unclear whether the patient version is as valid as the
clinician version.
Methods: We compared the patient-rated version of the Lifechart (LC-self) with the Young-Mania-Rating Scale
(YMRS), Inventory of Depressive Symptoms–Clinician version (IDS-C), and Clinical Global Impression–Bipolar version
(CGI-BP) in 108 bipolar I and II patients who participated in the Naturalistic Follow-up Study (NFS) of the German
centres of the Bipolar Collaborative Network (BCN; formerly Stanley Foundation Bipolar Network). For statistical
evaluation, levels of severity of mood states on the Lifechart were transformed numerically and comparison with
affective scales was performed using chi-square and t tests. For testing correlations Pearson´s coefficient was
calculated.
Results: Ratings for depression of LC-self and total scores of IDS-C were found to be highly correlated (Pearson
coefficient r = −.718; p < .001), whilst the correlation of ratings for mania with YMRS compared to LC-self were
slightly less robust (Pearson coefficient r = .491; p = .001). These results were confirmed by good correlations between
the CGI-BP IA (mania), IB (depression) and IC (overall mood state) and the LC-self ratings (Pearson coefficient r = .488,
r = .721 and r = .65, respectively; all p < .001).
Conclusions: The LC-self shows a significant correlation and good concordance with standard cross sectional affective
rating scales, suggesting that the LC-self is a valid and time and money saving alternative to the clinician-rated version
which should be incorporated in future clinical research in bipolar disorder. Generalizability of the results is limited by
the selection of highly motivated patients in specialized bipolar centres and by the open design of the study.
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Bipolar disorder is a life long and complex clinical entity.
Various manifestations of depression, mania, hypomania,
and mixed states characterize the mood-fluctuations,
with depressive episodes prevailing over manic or hypo-
manic episodes [1,2]. Even though research on bipolar
disorder has increased in the last two decades, accurate
diagnosis is still often delayed by 8 to 10 years [3,4].* Correspondence: christoph.born@med.uni-muenchen.de
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unless otherwise stated.Furthermore, finding optimal treatment gets more com-
plex as more options are available and as the course var-
ies markedly within the bipolar spectrum, including
rapid-cycling forms, mixed or psychotic features. The ill-
ness also often gets complicated by psychiatric comor-
bidities, such as substance use disorders, anxiety or
personality disorders. A further risk factor for a poorer
outcome might be the diagnosis bipolar II disorder with
more and longer duration of episodes and shorter dur-
ation of well intervals than in bipolar I patients [5].
Therefore, the accurate assessment and documentation
of the long-term course is pivotal to optimizing treatmentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tient [6]. One of the most widely used approaches to
document the course of bipolar disorders is based on the
observational research of Kraepelin in the early years of
the 20th century. The US National Institute of Mental
Health modified the methods of Kraepelin and created
the Life-chart Methodology (NIMH-LCM). The major
variable in the NIMH-LCM is four levels of depression
based on the degree of functional impairment related to
affective symptoms (from −1 slight or mild to −4 severe
and incapacitating depression) and similarly four degrees
of mania (from +1 mild to +4 severe mania), with 0 repre-
senting a balanced, well-functioning euthymic state. Add-
itionally, medications, life events, drug abuse, hours of
sleep, irritability, ultradian cycling, and co-morbidities are
documented on a daily basis in the prospective Life-chart.
By evaluating these items on a daily basis, decreasing
or increasing frequency and severity of episodes over
time, responders and non-responders to different medi-
cations and the impact of drug abuse and life events can
be easily identified. Also assessment of long term pat-
terns of response and sometimes its waning, as the phe-
nomena of tolerance and discontinuation refractoriness,
can be readily identified. Increasing appreciation of the
long term course of illness, and enhancement of the
therapeutic alliance and compliance are also by-products
of the LCM. We previously demonstrated that patients
using the NIMH-LCM regularly experience an increase
in euthymic days and a decrease in (subsyndromal) de-
pressive and (hypo)manic days [7].
The NIMH-LCM contains a retrospective chart using
monthly ratings [8] and a prospective chart using daily
ratings [9]. Furthermore, there is a patient-rated version
of the Life-chart (LC-self ) and a clinician-rated version
(LC-clinician) for both time domains. The prospective
LC-clinician is predominantly used in clinical and scien-
tific settings and has shown good validity and reliability
[10,11]. The LC-self collects the same information and
could represent a rapid and time saving source of infor-
mation for the clinician about the course of illness since
the last visit of the patient [12]. However, only the LC-
clinician has been validated so far.
Although the LC-self needs to be more formally vali-
dated for use in future trials, we performed this first
analysis to test whether the prospective LC-self shows
similar properties to the LC-clinician by comparison to
various mood scales in participants of the Naturalistic
follow-up study (NFS) of the Bipolar Collaborative Net-
work (BCN; formerly Stanley Foundation Bipolar Net-
work) [13].
Methods
We used the same methodology as proposed in earlier
validation studies of the clinician-LC [10,11]. The studywas approved by the local ethical committees in Munich
and Freiburg (reference number Munich 112a/99 and
Freiburg 114/99). After signing informed consent, pa-
tients from both German sites of the international BCN,
Munich and Freiburg, were included into the NFS. In-
clusion criteria for entry into the NFS were the diagnosis
of bipolar I, bipolar II, bipolar not otherwise specified or
schizoaffective disorder, bipolar subtype, and being
willed to attend at least monthly visits, participate in de-
tailed evaluations and prospective lifecharting. Patients
were only excluded in the case of current active sub-
stance abuse or imminent suicidal threat.
The detailed procedure of the NFS protocol has been
reported elsewhere [9,14]. The NFS was an open trial to
gather data about the naturalistic course of illness and
primarily not designed for the validation of the LC-self.
Nevertheless, we took advantage of this data to validate
also the LC-self. In line with the protocol of the NFS
every subject provided his prospective LC-self at each
monthly visit. The NFS protocol also required several
other cross sectional scales used at each visit, amongst
them the Young Mania Rating Scale (YMRS; [15]), the
Inventory of Depressive Symptoms-Clinician Version
(IDS-C; [16]), and the Clinical Global Impression-Bipolar
Version (CGI-BP; [17]). Unlike the IDS-C and the YMRS,
the CGI-BP ratings display a single estimation of the se-
verity of the overall mood syndrome (0 to 7) and not
evaluating different mood symptoms. Severity of the
acute manic syndrome is assessed by the CGI-BP IA rat-
ings, severity of the acute depressive syndrome by the
CGI-BP IB rating, and total severity of the illness by the
CGI-BP IC rating [17]. The rating of the YMRS includes
the last two days, the IDS-C the last week and the CGI-
BP the whole time since last visit, including the max-
imum or worst rating since last visit, while the Lifechart
was designed for daily rating. For validation with the
cross sectional scales, we used the average Lifechart rat-
ing of the same time frames used for each scale as noted
above. Raters were not blinded to the results of the cross
sectional scales when they were rating the LC-clinician.
All clinicians of the BCN received specific training for
using these instruments and inter-rater reliability was
checked. Patients also received standardized instructions
how to perform lifecharting, suggesting that it should be
carried out at the end of each day and linked to some
routine bed time activity such as brushing teeth or tak-
ing medications to facilitate the habit and reliability of
completing the LC self. For data processing the graphic
presentation of the Life-chart was then transformed into
numeric digits. As stated above, every level of mood
reaches from severe depression to severe mania being
represented by a number (from −4 to +4), while 0 was
considered as an euthymic state. Each severity grade of
illness was primarily linked to the degree of functional
Born et al. BMC Psychiatry 2014, 14:130 Page 3 of 7
http://www.biomedcentral.com/1471-244X/14/130incapacitation in a patient´s usual social, educational, or
occupational role and not necessarily with the subjective
perception of mood in order to facilitate the recall over
both retrospective and prospective time domains. Severe
depression (−4) was associated with essentially complete
incapacitation, high moderate depression (−3) with great
extra effort required to complete needed tasks, low mod-
erate depression (−2) with some extra effort being re-
quired, and mild depression (−1) with awareness of
depression, but associated with little or no functional in-
capacity. Euthymia (0) was defined as functioning with-
out any restrictions in daily life. Mild hypomania (+1)
imply even more productivity than usual, low moderate
hypomania (+2) some difficulty in goal directed activity,
high moderate mania (+3) with great difficulty in goal
directed activity, and severe mania (+4) essentially inca-
pacitaty or hospitalization.Statistics
Data were stored on an SQL-Server (DB2, Version 8.2).
For extraction of data the databank-management-system
OMNIS-Studio (Version 4.1) was used. Statistical calcula-
tion was performed by using the SPSS software (Version
11). For comparison of demographic data the chi-square
test and the t test were used, and to estimate correlations
Pearson´s coefficient was calculated.Results
Evaluable data sets of 108 of 140 patients participating
in the NFS from 1999 to 2002 at the German sites of the
BCN were available for the comparison of the LC-self
with the IDS-C, YMRS and CGI-BP. Basic demographic
data of our sample are given in Table 1. In this particular
subset of patients only 2 patients fulfilled diagnostic cri-
teria of schizoaffective disorder, bipolar type.
As a first step, we compared the daily LC-self versus
the IDS-C rated depressive symptoms. A strong correl-
ation was found between ratings of depression severity
on the LC-self and the total scores of the IDS-C (Pear-
son coefficient r = −.718; p < .001). We found a linearity
of this correlation when charting the average values of
the overall severity of depressive symptoms measured by
the IDS-C scores and the different levels of functioning
of the Life-chart (Figure 1).Table 1 Demographics
Female (n)
Bipolar I (n) 38 (74,5%)
Bipolar II (n) 12 (23,5%)
Schizoaffective, bipolar subtype (n) 1 (2%)
Age (mean ± SD) 38,8 ± 14,3 years
total (n) 51 (47,2%)As second step, we also compared the mania ratings on
the LC-self with the YMRS scores. Again, results were sta-
tistically significant (Pearson coefficient r = .491; p < .001)
and following a linear model (Figure 2).
Furthermore, we found a good correlation for the
CGI-BP IA with the LC-self for mania (Pearson coeffi-
cient r = .488; p < .001), for the CGI-BP IB with the LC-
self for depression (Pearson coefficient r = .721; p < .001),
and for the CGI-BP IC ratings which were correlated
with the absolute maximum of the LC-self rating (Pear-
son coefficient r = .65; p < .001).
Discussion
As stated in the introduction, the NIMH-LCM has been
found to be a useful tool both in clinical practice and trials
for the assessment and documentation of the long-term
course of bipolar disorders [10]. It has been widely used to
evaluate therapeutic interventions [18,19], especially in
studies of the SFBN. While the LC-clinician has shown
good validity and reliability when tested against standard
scales [10,11] such information had not been previously
available for the LC-self. To our best knowledge, this is
the first analysis aimed at a preliminary validation of the
daily prospective LC-self against well-validated clinician-
rated cross-sectional psychometric scales for the assess-
ment of manic and depressive symptoms. In a reasonable
number of bipolar outpatients, we found a highly signifi-
cant correlation and good concordance between the daily
LC-self and the clinician-rated scales for mania (YMRS
and CGI-BP IA), depression (IDS-C and CGI-BP IB) and
for the overall mood state (CGI-BP IC), suggesting good
reliability and validity for the LC-self. Results are very
similar to those of the earlier validation studies of the LC-
clinician [10,11], the methods of which we replicated.
While the NFS was not performed prospective for the pri-
mary purpose of validating the LC-self, we nevertheless
used this opportunity to retrospectively examine the data
for this preliminary first look at its performance character-
istic and analysis in comparison to well-known clinician
ratings.
Despite the general robust correlation demonstrated,
the results need to be viewed with caution and the
generalizability of our findings may be limited. Interest-
ingly, correlation of the LC-self on severe mania (level +4)
was less consistent than for moderate mania (level +3) asMale (n) Total (n)
40 (70,2%) 78 (72,2%)
16 (28,1%) 28 (25,9%)
1 (1,8%) 2 (1,9%)
39,8 ± 12,4 years 39,3 ± 13,3 years
57 (52,6%) 108 (100%)
AVG_IDCSCORE BY LCPS FUNCTION RATING
0
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Figure 1 Average IDS-Clinician Ratings for the lifechart functing rating values in the depressive and euthymic range (severe
depression: −4; high moderate depression: −3; low moderate depression: −2; mild depression: −; euthymia: +0).
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be a less good correspondence of the LC-self on severe
mania (level +4) than for moderate mania (level +3), as
shown in Figure 2. There are several possible interpreta-
tions, such as the lack of insight patients often present
with when severely manic. Furthermore, the lack of an ad-
equate sample size and therefore insufficient data at this
severity level might be also a likely contributor because
patients in this study were outpatients and rarely showed
full-blown manic symptoms.
In addition, the patient cohort in this trial was highly
selective as subjects were motivated to participate in a
longitudinal clinical research effort, agreed to be carefullyAVERAGE (IDSCORE) 
0
5
10
15
20
25
30
+0 +1 +
Figure 2 Average YMRS clinician ratings for the lifechart functioning
high moderate mania: +3; low moderate mania: +2; mild mania: +1; estudied and rated, and they received detailed instruction
sessions on the use of the daily Life-chart. For a reliable
future use of computer-based self-ratings for clinical and
scientific purposes, the provision of comprehensive in-
structions to patients, e.g. with training videos or other
methods, might be essential. Moreover, means of moni-
toring consistency in completion of the LC-self ratings
and/or encouraging their completion by phone calls, au-
tomated text messages, or other modes of feedback might
also be desirable.
Another methodological limitation is that NFS clini-
cians were at the same time raters and treating physi-
cians, and thus were not blinded to the LC-self whenBY LC SP FUNCTION
2 +3 +4
rating values in the manic and euthymic range (severe mania: +4;
uthymia: +0).
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risk of bias. Finally, missing data points, as seen in most
other long-term studies, did also occur in the NFS pro-
gram which may be problematic for such trials in general
[20]. This problem might improve with the establishment
computer-based self-ratings, as this would facilitate data-
management, the generation of automatic reminders, and
as well as reduce time- and money-consuming proce-
dures associated with paper and pencil forms.
In the past years several approaches have been used to
optimize the long-term documentation of the course in
bipolar disorders, but few have utilized daily ratings.
Small time windows, however, are of critical importance
given the extreme diversity of episode duration, fre-
quency, and patterning inherent in bipolar disorder
[2,5,21,22] and its multiplicity of Axis I, Axis II, and med-
ical co-morbidities.
Other methodological approaches to clinician-versus
patient-rating and usage of paper sheets versus computer-
based programs for data-collection have been utilized.
The NIMH-LCM contains both self- and clinician-
ratings, and the studies of the SFBN used paper sheets
for data collection. The STEP-BD Blank Mood Chart,
which was developed by Sachs and coworkers (available
at hppt://www.manicdepressive.org/images/samplechart.
gif ) is a self-rating instrument providing data also on
paper sheets. The Internal State Scale is another self-
rating instrument which showed good reliability and val-
idity in the early 1990s [23]. Further options include the
Patient Mood Chart (PMC), validated in a small cohort
in a nine month trial [24], and the ChronoRecord, a
personal-computer based program [25], which has been
validated for depression and mania [26,27]. Another elec-
tronic diary was developed by one of the authors (L.S.)
for the use on a palm-top computer. It uses the NIMH-
LCM for documentation and has shown good results in a
feasibility study [12] . Today the use of this program,
named “Personal Life-chart” (http://www.bipolar.de/) is
no longer restricted to palm-tops.
The implications of having an easy-to-use partially vali-
dated self rating instrument available for routine clinical
use in outpatient treatment are wide ranging. Self-rating
is essential to complement the information of the clin-
ician rating, and helps clinicians to gain insight into pa-
tients self-perceptions and details of illness variation,
necessary for the evaluation of short and long term treat-
ment response and remission [28]. Daily self-ratings can
be easily and rapidly performed by the patient, and the
patient plays an active part in the evaluation of the treat-
ment process in terms of responsibility, self-monitoring,
and seeking early treatment for emergent symptoms. In
appropriately motivated populations the LC self, also
would have a great potential for its use in a research
setting.The LCM and some of the other above mentioned
methods for documentation of the long-term course offer
obvious advantages in relation to other cross sectional
psychometric scales. First, the daily ratings should be
highlighted as necessary for the identification and docu-
mentation of frequent mood swings which occur in a
much higher proportion of patients than previously recog-
nized. For instance, ultra-rapid cycling with four or more
episodes/month occurs in some 40% of patients and ultra-
dian cycling in some 19%. It has also been shown that the
onset of depressive episodes is faster in patients with bipo-
lar versus unipolar depressive disorder [29]. Capturing de-
pressive (or manic) symptoms early will enhance the
chance of timely and successful intervention.
Another advantage of the LCM might be the fact that
the degree of mood-driven functional impairment is the
rated measure of severity rather than the rating of indi-
vidual mood symptoms. Remembering whether one was
able to go to work or function with no, some or much
difficulty is much more easily judged and remembered
across weeks to months than subtle differences in spe-
cific mood symptoms. This also may make this type of
self-ratings more reliable as the degree of functional in-
capacity is a behaviour manifestation and might be less
affected by subjectivity than evaluation of a multiplicity
of internal mood and anxiety symptoms. However, self-
rating of mood-driven functional impairment is also sub-
ject to bias because of the subjective view of the amount
of difficulty involved in completing ones’ educational,
occupational, or social roles. The most critical items in
terms of diverging opinion between clinicians and pa-
tients were in the severe range of manic symptoms
which may be confounded by poor insight. It is widely
recognized that the patients’ estimation of manic symp-
toms is a more difficult issue than self-rating of depres-
sion (e.g., [30]).
A further justifiable criticism of the NIMH-LCM is that
severity of mood and functional impairment can some-
times be markedly dissociated. For these instances the
NIMH-LCM also has another rating of mood on a 0
(most depressed ever) to 100 (most activated or manic
ever) scale (where 50 is balanced) that can be used to dis-
cern such disjunctions between mood and functional
incapacity.
Another issue is that many scales have been developed
for rating unipolar depression and do not capture the
complexities of affective symptoms in bipolar disorder.
A helpful rating scale for depression in bipolar disorders
has been developed by Berk et al. which also captures
mixed symptoms [31]. Self-rating scales for mania are
scarce and seldom used in clinical trials [30] but the AS-
18, a self-rating scale for bipolar disorder, has been de-
veloped to assess depressive, manic and mixed affective
states [32]. This scale is claimed to be time-efficient and
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scales for mania and depression.
Conclusions
In conclusion, we found good correlations of standard
affective rating scales with the LC-self. The use of the
LC-self might facilitate detailed data-collection in future
short- and long-term studies and reduce time- and
money-consuming hetero-rating procedures. Further-
more, it may even be amenable for large practical clinical
trials in the community, which are indispensable for the
study of the relative effectiveness and optimization of our
current treatment option for this complex and dynamic
disease.
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